Assessment of the susceptibility of mutant HIV-1 to antiviral agents-Reference-Cited by-同舟云学术

Assessment of the susceptibility of mutant HIV-1 to antiviral agents

Published:2010-05 Issue:2 Volume:165 Page:230-237
ISSN:0166-0934
Container-title:Journal of Virological Methods
language:en
Short-container-title:Journal of Virological Methods

Author:

Wang Ying-Jie,McKenna Philip M.,Hrin Renee,Felock Peter,Lu Meiqing,Jones Kristen G.,Coburn Craig A.,Grobler Jay A.,Hazuda Daria J.,Miller Michael D.,Lai Ming-Tain

Publisher

Elsevier BV

Subject

Virology

Reference31 articles.

1. Isolation and characterization of human immunodeficiency virus type 1 resistant to the small-molecule CCR5 antagonist TAK-652;Baba;Antimicrob. Agents Chemother.,2007

2. Evidence for gene expression by unintegrated human immunodeficiency virus type 1 DNA species;Brussel;J. Virol.,2004

3. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells;Burns;Proc. Natl. Acad. Sci. U.S.A.,1993

4. PL-100, a novel HIV-1 protease inhibitor displaying a high genetic barrier to resistance: an in vitro selection study;Dandache;J. Med. Virol.,2008

5. Salvage treatment with lopinavir/ritonavir (Kaletra) in HIV-infected patients failing all current antiretroviral drug families;de Mendoza;HIV Clin. Trials,2002

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. No antagonism or cross-resistance and a high barrier to the emergence of resistance in vitro for the combination of islatravir and lenacapavir;Antimicrobial Agents and Chemotherapy;2024-07-09

2. Potent targeted activator of cell kill molecules eliminate cells expressing HIV-1;Science Translational Medicine;2023-02-22

3. Islatravir Has a High Barrier to Resistance and Exhibits a Differentiated Resistance Profile from Approved Nucleoside Reverse Transcriptase Inhibitors (NRTIs);Antimicrobial Agents and Chemotherapy;2022-06-21

4. Advances in Laser Scanning Imaging Cytometry for High-Content Screening;ASSAY and Drug Development Technologies;2015-03

5. In VitroResistance Selection with Doravirine (MK-1439), a Novel Nonnucleoside Reverse Transcriptase Inhibitor with Distinct Mutation Development Pathways;Antimicrobial Agents and Chemotherapy;2014-11-10